APRISTOR Trademark

Trademark Overview

On Friday, December 15, 2017, a trademark application was filed for APRISTOR with the United States Patent and Trademark Office. The USPTO has given the APRISTOR trademark a serial number of 87722720. The federal status of this trademark filing is REGISTERED as of Tuesday, January 12, 2021. This trademark is owned by Context Biopharma, Inc.. The APRISTOR trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer

Pharmaceutical product evaluation; Pharmaceutical products development
apristor

General Information

Serial Number87722720
Word MarkAPRISTOR
Filing DateFriday, December 15, 2017
Status700 - REGISTERED
Status DateTuesday, January 12, 2021
Registration Number6245823
Registration DateTuesday, January 12, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 1, 2018

Trademark Statements

Goods and ServicesPharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer
Goods and ServicesPharmaceutical product evaluation; Pharmaceutical products development

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 2, 2018
Primary Code005
First Use Anywhere DateFriday, December 15, 2017
First Use In Commerce DateFriday, December 15, 2017
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, January 2, 2018
Primary Code042
First Use Anywhere DateFriday, December 15, 2017
First Use In Commerce DateFriday, December 15, 2017

Trademark Owner History

Party NameContext Biopharma, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPhiladelphia, PA 19103
Party NameContext Biopharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPhiladelphia, PA 19104
Party NameContext Biopharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPhiladelphia, PA 19104

Trademark Events

Event DateEvent Description
Monday, September 19, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, September 19, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, September 19, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, September 19, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, September 19, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, September 19, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, January 12, 2021REGISTERED-PRINCIPAL REGISTER
Friday, December 11, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, December 10, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, December 10, 2020EXAMINER'S AMENDMENT ENTERED
Thursday, December 10, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, December 10, 2020EXAMINERS AMENDMENT E-MAILED
Thursday, December 10, 2020SU-EXAMINER'S AMENDMENT WRITTEN
Thursday, April 30, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, April 30, 2020NON-FINAL ACTION E-MAILED
Thursday, April 30, 2020SU - NON-FINAL ACTION - WRITTEN
Thursday, March 5, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 4, 2020STATEMENT OF USE PROCESSING COMPLETE
Monday, March 2, 2020USE AMENDMENT FILED
Wednesday, March 4, 2020SOU EXTENSION 3 GRANTED
Thursday, December 26, 2019SOU EXTENSION 3 FILED
Monday, March 2, 2020TEAS STATEMENT OF USE RECEIVED
Monday, March 2, 2020NOTICE OF REVIVAL - E-MAILED
Monday, March 2, 2020EXTENSION RECEIVED WITH TEAS PETITION
Monday, March 2, 2020PETITION TO REVIVE-GRANTED
Monday, March 2, 2020TEAS PETITION TO REVIVE RECEIVED
Monday, January 27, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 27, 2020ABANDONMENT - NO USE STATEMENT FILED
Wednesday, September 25, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 24, 2019SOU EXTENSION 2 GRANTED
Wednesday, June 26, 2019SOU EXTENSION 2 FILED
Tuesday, September 24, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, July 31, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 31, 2019NOTICE OF REVIVAL - E-MAILED
Wednesday, July 31, 2019EXTENSION RECEIVED WITH TEAS PETITION
Wednesday, July 31, 2019PETITION TO REVIVE-GRANTED
Wednesday, July 31, 2019TEAS PETITION TO REVIVE RECEIVED
Monday, July 29, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 29, 2019ABANDONMENT - NO USE STATEMENT FILED
Wednesday, August 29, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 27, 2018SOU EXTENSION 1 GRANTED
Monday, August 27, 2018SOU EXTENSION 1 FILED
Monday, August 27, 2018TEAS EXTENSION RECEIVED
Tuesday, June 26, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 1, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 1, 2018PUBLISHED FOR OPPOSITION
Wednesday, April 11, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 27, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 27, 2018ASSIGNED TO EXAMINER
Tuesday, January 2, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, December 19, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

apristor pharmaceutical treatment products cancer evaluation product development viral prevention infectious